Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)
Title:
Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer – The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29)
Author:
von Minckwitz, G. Rezai, M. Tesch, H. Huober, J. Gerber, B. Zahm, D.M. Hilfrich, J. Costa, S.D. Dubsky, P. Blohmer, J.U. Denkert, C. Hanusch, C. Jackisch, C. Kümmel, S. Fasching, P.A. Schneeweiss, A. Paepke, S. Untch, M. Burchardi, N. Mehta, K. Loibl, S.